EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Pathogenic mechanism and therapeutic intervention of impaired N 7 -methylguanosine (m 7 G) tRNA modification

Jieyi Ma iD, Siyi Zheng iD, Chenrui An iD, Hui Han iD, Qiwen Li, Ying Huang, Gan Xiong, Shuang Chen, Siyao Guo, Zhaoyu Wang, Wei Wei, Yudan Shang und 7 weitere

Proceedings of the National Academy of Sciences · 2024

DOI: 10.1073/pnas.2405886121 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2024. Verfasst von Jieyi Ma und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory of General Surgery, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, China. Hauptthemen laut MEDLINE: RNA, Transfer, Methyltransferases, Guanosine. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Natural Science Foundation of Guangdong.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mutations modification enzymes including the tRNA N 7 -methylguanosine (m 7 G) methyltransferase complex component WDR4 were frequently found in patients with neural disorders, while the pathogenic mechanism and therapeutic intervention strategies are poorly explored. In this study, we revealed that patient-derived WDR4 mutation leads to temporal and cell-type-specific neural degeneration, and directly causes neural developmental disorders in mice. Mechanistically, WDR4 point mutation disrupts the interaction between WDR4 and METTL1 and accelerates METTL1 protein degradation. We further uncovered that impaired tRNA m 7 G modification caused by Wdr4 mutation decreases the mRNA translation of genes involved in mTOR pathway, leading to elevated endoplasmic reticulum stress markers, and increases neural cell apoptosis. Importantly, treatment with stress-attenuating drug Tauroursodeoxycholate (TUDCA) significantly decreases neural cell death and improves neural functions of the Wdr4 mutated mice. Moreover, adeno-associated virus mediated transduction of wild-type WDR4 restores METTL1 protein level and tRNA m 7 G modification in the mouse brain, and achieves long-lasting therapeutic effect in Wdr4 mutated mice. Most importantly, we further demonstrated that both TUDCA treatment and WDR4 restoration significantly improve the survival and functions of human iPSCs-derived neuron stem cells that harbor the patient’s WDR4 mutation. Overall, our study uncovers molecular insights underlying WDR4 mutation in the pathogenesis of neural diseases and develops two promising therapeutic strategies for treatment of neural diseases caused by impaired tRNA modifications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA, TransferMethyltransferasesGuanosineAnimalsHumansMiceApoptosisNeuronsEndoplasmic Reticulum StressMutationTaurochenodeoxycholic AcidGTP-Binding Proteins

Stichwörter der Autor:innen

N7-methylguanosine (m7G)WDR4gene therapyneural diseasestRNA modification

Substanzen

RNA, TransferMethyltransferasesGuanosineWDR4 protein, human7-methylguanosineMETTL1 protein, humanursodoxicoltaurineTaurochenodeoxycholic AcidGTP-Binding Proteins

Autor:innen und Institutionen

  • Department of Laboratory of General Surgery, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, China.
  • Department of Center for Translational Medicine, Institute of Precision Medicine, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, China.
  • Department of Obstetrics and Gynecology, Guangdong Provincial Key Laboratory of Major Obstetric Diseases, Guangdong Provincial Clinical Research Center for Obstetrics and Gynecology, The Third Affiliated Hospital of Gua…
  • Department of State Key Laboratory of Oral Diseases & National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, China.
  • Department of Pediatrics, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, China.
  • Department of Life Science, College of Natural Sciences, Hanyang University, Seoul 04763, Republic of Korea.

ORCID-Profile: Jieyi Ma, Siyi Zheng, Chenrui An, Hui Han, Junho Choe, Quan Yuan, Canfeng Zhang

Förderung

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China
  • Natural Science Foundation of Guangdong
  • Fundamental Research Funds for the Central Universities
  • Sun Yat-sen University
  • National Research Foundation of Korea

Zitieren

APA

Ma, J., Zheng, S., An, C., Han, H., Li, Q., Huang, Y., Xiong, G., Chen, S., Guo, S., Wang, Z., Wei, W., Shang, Y., Ji, Y., Yang, C., Choe, J., Yuan, Q., Fan, Y., Zhang, C., & Lin, S. (2024). Pathogenic mechanism and therapeutic intervention of impaired N 7 -methylguanosine (m 7 G) tRNA modification. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2405886121

Vancouver

Ma J, Zheng S, An C, Han H, Li Q, Huang Y, et al. Pathogenic mechanism and therapeutic intervention of impaired N 7 -methylguanosine (m 7 G) tRNA modification. Proceedings of the National Academy of Sciences. 2024. doi:10.1073/pnas.2405886121

BibTeX
@article{Ma2024,
  author = {Ma, Jieyi and Zheng, Siyi and An, Chenrui and Han, Hui and Li, Qiwen and Huang, Ying and Xiong, Gan and Chen, Shuang and Guo, Siyao and Wang, Zhaoyu and Wei, Wei and Shang, Yudan and Ji, Yushan and Yang, Cuiyun and Choe, Junho and Yuan, Quan and Fan, Yong and Zhang, Canfeng and Lin, Shuibin},
  title = {Pathogenic mechanism and therapeutic intervention of impaired N 7 -methylguanosine (m 7 G) tRNA modification},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2024},
  doi = {10.1073/pnas.2405886121}
}
Kostenlos starten →